Note 3 – Stockholders’ Equity and Share-Based Compensation

Common Stock Issuance

On September 8, 2025, the Company entered into a Purchase Agreement with certain investors. The Company issued and sold an aggregate of 10,319,727 shares of common stock, par value $0.001 per share, resulting in gross proceeds of $10,733.

Options and Restricted Stock Units

The Company had the following common stock option activity during the thirty-nine weeks ended September 27, 2025:

The following table summarizes the Company’s restricted stock unit ("RSU") and restricted stock award (“RSA”) activity for the thirty-nine weeks ended September 27, 2025, and details regarding the awards outstanding and exercisable as of September 27, 2025 (in thousands):

​

During the thirty-nine weeks ended September 27, 2025, 1,800 RSUs that vested were time-based.

For the thirteen and thirty-nine weeks ended September 27, 2025, we recorded compensation costs related to stock options, RSUs and RSAs of $2,472 and $8,119, respectively. For the thirteen and thirty-nine weeks ended September 28, 2024, we recorded compensation costs related to stock options and RSUs of $3,187 and $9,528, respectively. As of September 27, 2025, there was unrecognized compensation expense related to stock options, RSUs and RSAs of $7,954 that will be expensed through September 2029.